However, FBXW7 double mutations completely block FBXW7 activity, thereby providing a free hand to NOTCH, c‐Myc, and several other substrates in facilitating the T‐ALL resistance against GSIs. The gene discussed is FBXW7; the disease is acute lymphoblastic leukemia.